Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials

被引:0
|
作者
Thomas G. Nührenberg
Willibald Hochholzer
Kambis Mashayekhi
Miroslaw Ferenc
Franz-Josef Neumann
机构
[1] University Heart Center Freiburg—Bad Krozingen,Department of Cardiology and Angiology II
来源
关键词
Acute coronary syndrome; Percutaneous coronary intervention; Bivalirudin; Heparin; Glycoprotein inhibitors; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:807 / 815
页数:8
相关论文
共 50 条
  • [31] Safety and efficacy of bivalirudin in acute coronary syndromes
    Hartmann, F.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (12) : 1191 - 1196
  • [32] Mortality and operator experience with vascular access for percutaneous coronary intervention in patients with acute coronary syndromes: A pairwise and network meta-analysis of randomized controlled trials
    Shah, Rahman
    Askari, Reza
    Haji, Showkat A.
    Rashid, Abdul
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 114 - 119
  • [33] Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials
    Jing, Yunyan
    Ni, Bin
    Zhou, Donglai
    Zhang, Xingwei
    Liu, Shanxin
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (02) : 122 - 126
  • [34] Bivalirudin versus unfractionated heparin for percutaneous coronary intervention with radial access: A meta-analysis of randomized trials
    Mahmoud, Ahmed N.
    Elgendy, Islam Y.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 216 : 128 - 132
  • [35] Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials
    Saad, Marwan
    Gamal, Amgad
    Nairooz, Ramez
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B85 - B85
  • [36] Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
    Cavender, Matthew A.
    Sabatine, Marc S.
    [J]. LANCET, 2014, 384 (9943): : 599 - 606
  • [37] Efficacy and Safety of Shortened Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Hui, Jiaojiao
    Bai, Ting
    Liang, Le
    He, Qingqing
    Tian, Nani
    Li, Xiao
    Yang, Rui
    Zhu, Lin
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (05) : 700 - 708
  • [38] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials
    Zhu, Jianbing
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C132 - C132
  • [39] SAFETY AND EFFICACY OF ORAL FACTOR XA INHIBITORS IN PATIENTS WITH ACUTE CORONARY SYNDROMES: A SYSTEMIC META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Singh, Mukesh
    Moningi, Srikanth
    Shah, Tejaskumar
    Arora, Rohit
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E525 - E525
  • [40] Efficacy and safety of bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized trials
    Jiang, Long
    Cheng, Xiaoshu
    Yang, Renqiang
    Hu, Lijuan
    Fan, Yingli
    Zhan, Rui
    [J]. CARDIOLOGY, 2013, 126 : 135 - 136